News and Trends 21 Nov 2022
Immorna cleared for mRNA-based Covid-19 vaccine study
U.S. biotech company Immorna says the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to conduct a phase 1/2 multi-center study of JCXH-221, a lipid…